Cdc7-IN-7

• UNSPSC Description:

  Cdc7-IN-7 (compound I-E) is a potent Cdc7 kinase inhibitor extracted from patent WO2019165473A1, compound I-E. Cdc7 is a serine-threonine protein kinase enzyme which is essential for the initiation of DNA replication in the cell cycle[1].

• Target Antigen:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdc7-in-7.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C(C/1=O)=C(NN2CCOCC2)OC1=C/C3=CNC4=NC=CC=C43)OCC5CC5

• Molecular Weight:

  410.42

• References & Citations:

  [1]Christian Andrew HASSIG, et al. Methods of treatment of cancer comprising cdc7 inhibitors. WO2019165473A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1402059-17-9